Cell Genesys, Inc. (CEGE)

S&P 500: 1,056.89
Change: -3.85%

A biotechnology company focused on the development and commercialization of novel biological therapies for patients with cancer.

Recs

Avatar obenation (53.89) Submitted: 4/30/07 7:15 PM : Start Price: $4.36 CEGE Score: -56.80

this is a short term momentum play assuming DNDN is approved

Featured Broker Partners